Document is current
Any future updates will be listed below
-
Authors
Delgado-Wicke, Pablo
Fernández de Córdoba-Oñate, Sara
Roy-Vallejo, Emilia
Alegría-Carrasco, Estíbaliz
Rodríguez-Serrano, Diego A.
Lamana, Amalia
Montes, Nuria
Nicolao-Gómez, Ana
Carracedo-Rodríguez, Rosa
Marcos-Jiménez, Ana
Díaz-Fernández, Paula
Galván-Román, José M.
Rabes-Rodríguez, Laura
Sanz-Alba, Marta
Álvarez-Rodríguez, Jesús
Villa-Martí, Almudena
Rodríguez-Franco, Carlos
Villapalos-García, Gonzalo
Zubiaur, Pablo
Abad-Santos, Francisco
de los Santos, Ignacio
Gomariz, Rosa P.
García-Vicuña, Rosario
Muñoz-Calleja, Cecilia
González-Álvaro, Isidoro
Fernández-Ruiz, Elena
,
Suárez Fernández, Carmen
Barrios, Ana
Sanz, Jesús
Casado, Pedro
Gutiérrez, Ángela
Bautista, Azucena
Hernández, Pilar
Ruiz Giménez, Nuria
Moyano, Berta
Gil, Paloma
Delgado, María Jesús
Parra, Pedro
Sánchez, Beatriz
Sáez, Carmen
Fernández-Rico, Marta
Arévalo-Román, Cristina
Ciudad, Marianela
Castañeda, Santos
Llorente, Irene
Tomero, Eva G.
García-Castañeda, Noelia
Uriarte, Miren
Cardeñoso, Laura
Fontán García-Rodrigo, Leticia
García, Diego Domingo
Alarcón-Cavero, Teresa
Semiglia Chong, María Auxiliadora
Gutiérrez-Cobos, Ainhoa
Zurita-Cruz, Nelly D.
Sánchez-Madrid, Francisco
Martín-Gayo, Enrique
Sánchez-Cerrillo, Ildefonso
Martínez-Fleta, Pedro
López-Sanz, Celia
Gabrie, Ligia
del Campo-Guerola, Luciana
Tejedor, Reyes
Ancochea, Julio
García-Castillo, Elena
Ávalos, Elena
Sánchez-Azofra, Ana
Alonso, Tamara
Cisneros, Carolina
Valenzuela, Claudia
García-Pérez, Francisco J.
Girón, Rosa M.
Aspa, Javier
Marcos, Celeste
del Perpetuo Socorro Churruca, M.
Zamora, Enrique
Martínez, Adrián
Barrio-Mayo, Mar
Henares-Espi, Rosalina
Méndez, Rosa
Arribas, David
Chicot-Llano, Marta
González, Begoña
Quicios, Begoña
Patiño, Pablo
Trigueros, Marina
Dominguez-Peña, Cristina
Jiménez-Jiménez, David
Villamayor, Pablo
Canabal, Alfonso
de la Cámara, Rafael
Ortiz, Javier
Iturrate, Isabel
- License Information
-
More Information
Article History
Received: 14 December 2023
Accepted: 28 August 2024
First Online: 5 September 2024
Competing interests
: TFA-S has been consultant or investigator in clinical trials sponsored by the following pharmaceutical companies: Abbott, Alter, Aptatargets, Chemo, FAES, Farmalider, Ferrer, Galenicum, GlaxoSmithKline, Gilead, Italfarmaco, Janssen-427 Cilag, Kern, Normon, Novartis, Servier, Teva and Zambon. IG-Á reports personal fees from Lilly and Sanofi; personal fees and non-financial support from BMS; personal fees and non-financial support from Abbvie; research support, personal fees and non-financial support from Roche Laboratories; research support from Gebro Pharma; non-financial support from MSD, Pfizer and Novartis, not related to the submitted work. RGV declares educational or research grants for her institution from Abbvie, Lilly, Janssen, MSD, Novartis, Sanofi and UCB; consultancies/speaking personal fees from Abbvie, Biogen, MSD, Pfizer, Sandoz and UCB; non-financial support from Abbvie, Janssen, Lilly, MSD, Novartis, Pfizer and UCB, all outside the present work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: his study was approved by the Research Ethics Committee of University Hospital La Princesa, Madrid (register number 4070, March 30th 2020), and it was carried out following the ethical principles of the Declaration of Helsinki. All patients were informed about the study and gave oral or written consent to participate, which was registered in their electronic clinical chart. Due to the COVID-19 pandemic emergency, oral consent was accepted as proposed by the AEMPS (Agencia Española de Medicamentos y Productos Sanitarios, The Spanish Agency for Medicines and Medical Devices) in April 2020. Due to the periodical medical supervision, the written consent of the people living with HIV was subsequently obtained. This article was written following the STREGA (STrengthening the REporting of Genetic Association studies) guidelines (Table ).
